Customized cord blood-derived dendritic cells to get better disease control in refractory AML

【Author】

Maud Plantinga;Niek P.van Til;Colin de Haar;Ester Dünnebach;Timo Peters;Jaap J.Boelens;Stefan Nierkens;

【Abstract】

<正>Pediatric patients with relapsed acute myeloid leukemia(AML)have a very poor survival,despite the last treatment option,hematopoietic(stem)cell transplantation(HCT).Cord blood(CB)as a stem cell source provides better disease control,compared to bone marrow or peripheral blood.CB T-cells are mostly na?ve and display an exceptional proliferative capacity,making them potential targets for

【Keywords】

refractory;hematopoietic;proliferative;exceptional;myeloid;mostly;option;despite;vaccines;phenotype;

References

To explore the background and basis of the node document

Springer Journals Database

Total: 0 articles

Similar documents

Documents that have the similar content to the node document

Springer Journals Database

Total: 0 articles